ALIPIO MASCARENHAS: Open Payments
NPI 1861467912 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 8 payments from 4 companies in 2025. Trend: 2023 $494 · 2024 $228 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| ABBVIE INC. | 2 | $57 |
| Alkermes, Inc. | 2 | $44 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: COBENFY, VRAYLAR, ARISTADA, INGREZZA.
Industry payments across TX — which companies pay providers there.
